Abstract

Diabetes mellitus is a chronic metabolic disease characterized by elevated blood glucose levels and has become a global challenge. Currently, the widespread and regular treatment of diabetes mellitus involves the administration of insulin. However, insulin is no longer considered the first choice for type 2 diabetes, and an expanding range of new treatment modalities are emerging as noninsulin-based medications that are promising alternatives to regulate blood glucose levels. In this regard, controlling the glucose level in blood by external stimuli, such as light, offers a new route to governing the blood glucose concentration with the required dose and at the appropriate time. Here, we report on a light-stimulated glucose-lowering method based on spiropyran-merocyanine photoisomerization. We show that upon exposure to violet light (405 nm), the closed isoform of spiropyran molecules inside liquid crystal microspheres transforms into the open merocyanine isoform, which in turn stimulates merocyanine to translocate through the interface of the liquid crystal/dextrose emulsion. Merocyanine readily interacts with glucose molecules and causes a lowering of the emulsion’s total glucose concentration by 20 %.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.